NIH Hid Public Comments Package, pp.99-100 · nih_public_comments:email:00103
Page text: p.99, p.100 · original PDF
- Date
- 2022-01-14 09:22
- Type
- email · email
- cc
- Crystal Spruill, Scott Prince, David Lankford, Renate Myles, Lydia Polimeni, Amanda Fine, Haley Spencer
- sender
- Sarah J. Imhoff
- to
- Anna Kern
This text appears inside a quoted reply chain — it is evidence that the message was circulating, not necessarily a new message.
f(OD)[
Lankford,
nate (NIH/OD) [E]
limeni, Lydia
<
<
@palladianpartners.com>
Subject: RE: PETA Lawsuit Update and Requests for Information
Hi everyone,
I have two additional follow-up questions from the DOJ:
1. Were the twitter posts on the 10/3/14 discussion on brain health linked below posted directly on NIH's Twitter
account main page? Or was there a separate "chat" where these were posted? Plaintiffs want to know if anyone
that went to the NIH's twitter account during that time would have seen those posts.
2. Are you aware of complaints we've received against other types of posts, unrelated to animal testing? E.g., posts
concerning Dr. Fauci, or posts concerning vaccine misinformation? I know I've asked this before, but Plaintiffs
specifically want to know if the complaints NIH receives are really focused on PETA, or if NIH received complaints
about inflammatory posts on a variety of subjects. I think Plaintiffs want to make the argument that NIH is targeted
animal rights posts over other inflammatory posts when they are equally inappropriate. Since Plaintiffs want this
answer as part of our fact stipulation negotiations, I think we have to provide it.
Thank you,
Sarah J. Imhoff, JD, MHSA
Senior Attorney
Office of the General Counsel
Public Health Division, NIH Branch
(direct)
@nih.gov
This e-mail message is intended for the exclusive use of the recipient(s) named above. It may contain information that is protected,
privileged, or confidential, and it should not be disseminated, distributed, or copied to persons not authorized to receive such
information. If you are not the intended recipient, any dissemination, distribution, or copying is strictly prohibited. If you think you
have received this e-mail message in error, please notify the sender immediately.